Huaxin Cement Co. Ltd. (6655)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 23 Oct 2026
Key indicators
| Last close | HKD 15.68 |
|---|---|
| 52-week range | 11.35 – 20.20 |
| Return, 1 month / 3 months | +0.1% / +6.3% |
| Return, 1 year / 3 years | +1.7% / +164.0% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 42.2% |
| Worst drawdown (1 year) | -41.5% |
| Average daily value traded | 39.99M HKD |
| Dividend yield | 3.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Huaxin Cement is a Chinese building materials company based in Wuhan that makes cement, clinker and ready-mixed concrete for construction projects, infrastructure work and property development. It also produces aggregates and runs environmental services that use cement kilns to process waste. Its customers are mainly construction firms, concrete producers and industrial users, and the company operates plants in China as well as in several other countries.
On this site Huaxin Cement Co. Ltd. appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 6655, with prices in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Huaxin Cement Co. Ltd. (6655) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 15.68 on 23 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 424 of 2,613 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.7% and over the last three months it rose 6.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -0.4% | ||
| From 52-week high | -21.8% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.3% | ||
| 6-month return | -5.0% | ||
| 12-month return, skipping the last month | 1.5% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 42.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.5% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 39.99M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 48 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.3% |
|---|---|
| 1 month | +0.1% |
| 3 months | +6.3% |
| 6 months | −5.0% |
| 1 year | +1.7% |
| 3 years | +164.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 15.43 / 15.74 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.61 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jun 2026 | HKD 0.2413 |
| 14 Nov 2025 | HKD 0.3728 |
| 29 May 2025 | HKD 0.5015 |
| 24 May 2024 | HKD 0.5820 |
| 24 May 2023 | HKD 0.5677 |
| 24 May 2022 | HKD 1.1756 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.